Viking Therapeutics’ new contract is a game changer. Here’s how much money it could bring in.
Analysts, who are highly bullish on the stock, have fretted for some time that Viking needed a partner to actually make the ...
Zacks Investment Research on MSN8h
How to Play VKTX Stock Amid Manufacturing Deal With CordenPharma
Shares of Viking Therapeutics VKTX gained more than 11% on Wednesday after the company announced that it had signed a broad ...
Viking Therapeutics: Signs Of Insufficient Differentiation In Obesity Treatment (Rating Downgrade)
Viking Therapeutics' plans to launch VK2735 with an auto-injector could delay regulatory approval. Click here to read why ...
PharmExec2d
Viking Therapeutics, CordenPharma Strike Multi-Year Deal to Commercialize VK2735 for Obesity, Metabolic Disorders
Partnership is expected to support Phase III development of VK2735 in patients with obesity and metabolic disorders amid ...
Why Viking Therapeutics and Roche Holdings Popped Today, but Novo Nordisk Stock Dropped
Over the past few days, as the rest of the stock market melted down, a revolution has been quietly brewing in the market for ...
Viking Therapeutics Is Ready For A Standalone Future
Viking announced a supply deal with CordenPharma that sets it up for a standalone path to the obesity market. Read why I ...
Viking manufacturing agreement removes key overhang, says Morgan Stanley
After Viking Therapeutics (VKTX) announced a multi-year manufacturing agreement with CordenPharma to support the commercialization of VK2735, ...
Fierce Pharma2d
Viking pays $150M to recruit CordenPharma for obesity drug manufacturing saga
Less than a year after CordenPharma earmarked a major chunk of change to beef up in peptide manufacturing for GLP-1s and ...
Viking Therapeutics closer to bringing its Ozempic competitor to market
Viking Therapeutics (VKTX), the developer of a promising experimental weight-loss drug, has announced a multi-year ...
BioPharma Dive2d
Viking inks CordenPharma deal to boost obesity drug supply
The biotech will commit $150 million to an alliance that hands it significant production capacity for a closely watched ...
Viking Therapeutics signs broad manufacturing agreement with CordenPharma
Viking Therapeutics (VKTX) announced that it has signed a broad, multi-year manufacturing agreement with CordenPharma, a contract development ...
Viking Therapeutics Signs Broad Manufacturing Agreement With CordenPharma to Support Commercialization of VK2735
Viking Therapeutics, Inc. ("Viking") (NASDAQ: VKTX), a clinical-stage biopharmaceutical company focused on the development of novel therapies for metabolic and endocrine disorders, today announced ...